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ABSTRACT
Objective: The aim of this study was to know the incidence of erectile dysfunction (ED) after transurethral resections of the 
prostate (TURP) and transvesical prostatectomy (TVP). Material & method: Data were collected in 1 year period from January 
until December 2005 with cross sectional study design. There were 60 patients who met the inclusion and exclusion criteria and 
patient who participated in this study underwent TURP and TVP and divided in TURP group and TVP group. Erectile 
Dysfunction measured by International Index of Erectile Function-5 (IIEF-5) data was analyzed by statistic chi-square and 
independent t-test. Results: Sixty patients include this study with 30 patients in each group. The mean age of TURP was 64 ± 
5,68 and TVP was 63,23 ± 4,83 with age ranging from 50 – 70 years. The incidence of ED after TURP and TVP was 36,67% and 
16,70% respectively with p = 0,08. The IIEF-5 scores for TURP and TVP was 19,40 ± 3,95 and 21,03 ± 2,57 respectively and by 
statistical analysis the differences was not significant. Conclusion: The incidence of ED after TURP showed higher than TVP 
and by statistical analysis the differences was not significant.
Keywords: Benign prostatic hyperplasia, erectile dysfunction, transurethral resection of the prostate, transvesical             
      prostatectomy.
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ABSTRAK
Tujuan Penelitian: Tujuan dari penelitian ini adalah untuk mengetahui angka kejadian Disfungsi Ereksi (DE) setelah tindakan 
reseksi prostat transurethral (TURP) dan prostatektomi transvesika (TVP). Bahan & Cara: Pengumpulan data dilakukan 
dalam kurun waktu 1 tahun, mulai bulan Januari sampai Desember 2005. Didapatkan 60 pasien yang memenuhi kriteria 
inklusi dan eklusi, dan pasien yang berpartisipasi pada penelitian ini dilakukan Reseksi prostat transurethral dan 
prostatektomi transvesika dan dibagi dalam kelompok Reseksi prostat transurethral dan prostatektomi transvesia. DE diukur 
dengan International Index of Erectile Function-5 (IIEF-5), data dianalisa secara statistik dengan metode chi-square dan 
independent t-test. Hasil Penelitian: Enam puluh pasien yang mengikuti penelitian ini dibagi menjadi dua kelompok dengan 
masing-masing kelompok berjumlah 30 pasien. Rerata usia yang dilakukan reseksi prostat transurethral adalah 64 ± 5,68 dan 
prostatektomi transvesika adalah 63,23 ± 4,83 dengan usia berkisar dari 50 - 70 tahun. Angka kejadian DE setelah reseksi 
prostat transurethral and prostatektomi transvesika adalah 36,67% dan 16,70% dimana p = 0,08. Skor IIEF-5 reseksi prostat 
transurethral and prostatektomi transvesika adalah 19,40 ± 3,95 dan 21,03 ± 2, dan ini tidak berbeda secara signifikan. 
Simpulan: Angka kejadian DE setelah reseksi prostat transurethral lebih tinggi dari prostatektomi transvesika namun tidak 
berbeda secara signifikan.
Kata Kunci: Pembesaran prostat jinak, disfungsi ereksi, reseksi prostat transurethra, prostatektomi transvesika.
INTRODUCTION
Benign prostatic hyperplasia (BPH) is but one 
cause of the LUTS in aging men commonly. Ekman 
suggested that the increase in the fibro muscular 
1stroma is a result of sexual activity,  and many 
authors since then have attempted to find relevant 
2associations,  reported a 49% reduction in risk for 
prostatectomy in widowed versus single men. Similar 
association could not be verified by other authors. The 
decrease in sexual ability and frequency of sexual 
activity with advancing age, exactly when the 
prevalence of BPH increases, in fact might suggest a 
reverse relationship, namely, a causative effect of BPH 
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3on sexual function.  More recent evidence suggests 
that when controlling for age, increased symptom 
severity is associated with an increased risk for 
4erectile dysfunction.
The International Prostate Symptom Score 
(IPSS), which is identical to the AUA Symptom 
Index, is recommended as the symptom scoring 
instrument to be used for the baseline assessment of 
5,6symptom severity in men presenting with LUTS.  
When the IPSS system is used, symptoms can be 
classified as mild (0 to 7), moderate (8 to 19), or 
severe (20 to 35). The symptom score should also be 
the primary determinant of treatment response or 
7disease progression in the follow-up period.
After patients have been evaluated, they should 
be informed of the various therapeutic options for 
7BPH.  Specific treatment recommendations can be 
offered for certain groups of patients. For those with 
mild symptoms (symptom score 0-7), watchful 
waiting only is advised. On the other end of the 
therapeutic spectrum, absolute surgical indications 
include refractory urinary retention (failing at least 
one attempt at catheter removal), recurrent urinary 
tract infection from BPH, recurrent gross hematuria 
from BPH, bladder stones from BPH, renal insuffi-
5ciency from BPH, or large bladder diverticula.
Open simple prostatectomy When the prostate is 
too large to be removed endoscopically, an open 
enucleation is necessary. What constitutes "too large" 
is subjective and will vary depending upon the 
surgeon's experience with (transurethral resections of 
the prostate) TURP. Glands over 100 g are usually 
considered for open enucleation. Open prostatec-
tomy may also be initiated when concomitant bladder 
diverticulum or a bladder stone is present or if dorsal 
7,8lithotomy positioning is not possible,  such as a man 
presents with ankylosis of the hip or other orthopedic 
conditions Also, it may be wise to perform an open 
prostatectomy in men with recurrent or complex 
urethral conditions, such as urethral stricture or 
previous hypospadias repair, to avoid the urethral 
8trauma associated with TURP.  
Urethral strictures are the most common late 
complication of transurethral prostate surgery. They 
should be considered in any patient who underwent 
TURP who has symptoms of outlet obstruction or a 
peak flow rate of 10 mL/s or less. Urethral strictures 
or bladder neck contractures appear in 3,7% of 
patients. Strictures occur because of insertion of a 
resectoscope sheath that is too large urethral trauma 
during the procedure, use of a large-caliber catheter, 
9or infection.  
The etiology of bladder neck contractures is less 
certain, although they definitely seem to be related to 
the size of the gland, with smaller prostates being 
more likely to produce a bladder neck stricture than 
larger glands. Bladder neck contractures are less 
common after open prostatectomy, probably because 
of the very large size of the prostates normally 
resected at open surgery. Bladder neck contractures 
typically start to occur 4-6 weeks after transurethral 
9prostate surgery.  
Risks of TURP include retrograde ejaculation 
7(75%),  retrograde ejaculation results from the 
destruction of the bladder neck during TURP. During 
normal ejaculation, the bladder neck closes under 
sympathomimetic influence, allowing the semen to 
flow forward. The bladder neck is unable to close 
after TURP, permitting semen to flow backwards into 
the bladder. This is a very common sequela after 
TURP, occurring in 70,4% of patients. This should be 
carefully discussed with the patient before surgery 
because many patients confuse ejaculation with 
potency and may incorrectly consider themselves to 
be sexually impotent. It also may be quite alarming to 
the patient to unexpectedly find that he has a dry 
9ejaculate after a TURP.  
Erectile dysfunction occurs in 3-5% of patients 
undergoing an open prostatectomy, it is more 
common in older men than in younger men. 
Retrograde ejaculation occurs in 80-90% of patients 
after surgery. The risk of this adverse effect is reduced 
if the bladder neck is preserved at the time of surgery. 
Also, 2-3% of patients will develop a bladder neck 
contracture 6 to 12 weeks after an open 
prostatectomy. This commonly occurs in men who 
have a relatively small opening at the bladder neck at 
8the end of the operation.  
OBJECTIVE
The aim of this study was to know the incidence 
of erectile dysfunction (ED) after transurethral 
resections of the prostate (TURP) and transvesical 
prostatectomy (TVP).
MATERIAL & METHOD
This was cross sectional study design. Data were 
collected in 1 year period from January until 
December 2005 in Sardjito Hospital Yogyakarta. 
There were 60 patients who met the inclusion and 
exclusion criteria. The inclusion criteria included 
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patients who agreed to underwent prostatectomy, 
their aged was 50 to 70 years old, did not have 
erectile dysfunction before, sexually active, did not 
have any chronic disease such as diabetic mellitus, 
hypertension, systemic heart disease and chronic 
obstruction pulmonary diseases. The exclusion 
criteria were patient who did not agree to undergo 
prostatectomy and whom histopathological result 
was prostate cancer. 
Patient who participated in this study underwent 
TURP and TVP and divided in TURP group and 
TVP group. They asked to answer IPSS and IIEF-5 
questionnaire before prostatectomy and 3 months 
after prostatectomy they asked for IIEF-5 
questionnaire to evaluate ED. Data was analyzed by 
statistic chi-square and independent t-test.
RESULTS
The characteristic of the subject was listed in 
table 2. The mean age was 64,03 ± 5,68 for TURP 
and 63,23 ± 4,83 for TVP with age ranging from 50 – 
70 years old. The most common occupation for 
TURP (59,38%) was civil servant and private officer 
and for TVP were farmer and worker (60,71%). The 
academic level was advanced for TURP (60,87%) 
and elementary for TVP (56,76%). Urban area was 
the most common patient came from for TURP 
(60,87%) and for TVP was came from rural area 
(60,00%). The comparison of IPSS between TURP 
and TVP was 22,70 ± 3,2721 and 17 ± 3,28 
respectively by statistical analysis the differences 
was not significant.
The comparison between IIEF-5 scores after 
TURP and TVP was not significant (p > 0,05). The 
incidence of ED between TURP and PTV was not 
significant (p > 0,05) and the differences between 
age and incidence of ED was not significant.
The IPSS was used to evaluate the symptoms of 
BPH and the differences between IPSS and the 
incidence of ED was not significant, although 
subject who did not have ED showed IPSS lower 
than subject who had ED. The comparison between 
severe IPSS before prostatectomy and incidence of 
ED after prostatectomy was not significant (p > 
0,05).
The comparison between IIEF-5 scores before 
operation and the incidence of ED was not 
significant (p > 0,05).The comparison between 
academic level and the incidence of ED was not 
significant (p > 0,05) and the comparison between 
the incidence of ED and demographic was not 
significant (p > 0,05).
DISCUSSION
BPH is the most common benign tumor in men, 
and its incidence is age-related. The prevalence of 
histology BPH in autopsy studies rises from 
approximately 20% in men aged 41 – 50, to 50% in 
men aged 51 – 60, and to over 90% in men older than 
780.  Surgery is still an option to improve the IPSS and 
objectively will increase the flow of urine. TURP and 
TVP are common to procedures for BPH clinical. 
These procedures have advantages and disadvan-
tages, and one of the complications is ED.
This study was performed in Sardjito Hospital 
and 60 BPH patients were participated (30 TURP 
patients and 30 TVP patients). The mean age was 
64,03 ± 5,68 for TURP and 63,23 ± 4,83 for TVP with 
age ranging from 50 – 70 years old. The most 
common occupation was farmer and worker. The 
academic level was elementary, and urban area was 
the most common patient.
The comparison of IPSS between TURP and 
TVP was 22,70 ± 3,2721 and 17 ± 3,28 respectively 
by statistical analysis the differences was not 
significant. The comparison of IIEF-5 scores before 
prostatectomy between TURP and TVP was 
significant (p < 0,05) but clinically the IIEF-5 scores 
for TURP group (22,30) and TVP group (23,40) was 
not significant because the IIEF-5 scores was not in 
ED diagnosis scores.
The incidence of ED for TURP group was 
36,67% and for TVP group was 16,70% respectively. 
The mean IIEF-5 scores after TURP was 19,40 and it 
was lower than PRV group (21,03). Thierny et al 
found the incidence of ED after TURP was higher 
10than TVP (25,7% vs. 19,0%).  Another study 
Poulakis et al found the ED after TURP rate was 
1165%,  Ozkara et al found the incidence of ED after 
12TURP and TVP was 18 from 58 patients,  
meanwhile Pawlicki B et al found the incidence of 
13ED was 25%,  Taher A found the incidence of ED 
14after TURP was 14%,  Oh SK et al reported the 
15incidence of ED after TURP was 43%.  Erectile 
dysfunction occurs in 3% to 5% of patients 
8 undergoing an open prostatectomy. These study 
showed that incidence of ED afar TURP was higher 
than TVP but by statistical analysis the difference 
was not significant. It was understood, the TURP was 
done with resectoscope via urethra and the adenoma 
was resected by cutting loop using thermal energy 
(electrocauter) and it may damage nerve tissue 
including n.pudendus. In the other hand, PTV 
removed only the hyperplasic prostate.
10
CONCLUSION
In this study we found that the incidence of ED 
after TURP was higher than TVP but no significant 
difference between both procedures. TURP and PTV 
are acceptable procedures for BPH clinical. 
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